Related Experiment Videos
Diagnosis and medical management of patients with intermittent claudication
1Department of Vascular Medicine, Cleveland Clinic Foundation, OH 44195, USA. lapernl@ccf.org
Insights
Intermittent claudication management involves addressing atherosclerosis risk factors to prevent cardiovascular events. Exercise is key for improving daily function in patients with claudication symptoms.
Area of Science:
- Vascular Medicine
- Cardiovascular Disease
- Atherosclerosis Research
Background:
- Intermittent claudication is a symptom of atherosclerosis in the aorta and lower extremities.
- It signifies systemic atherosclerosis, necessitating comprehensive risk factor management.
- Management must address both cardiovascular event reduction and functional improvement.
Purpose of the Study:
- To outline the management strategies for intermittent claudication.
- To emphasize the importance of treating underlying atherosclerosis risk factors.
- To highlight the dual goals of reducing cardiovascular morbidity/mortality and improving patient function.
Main Methods:
- Conservative management, including pharmacologic and rehabilitative approaches (exercise), is favored for mild to moderate symptoms.
- Exercise is identified as the cornerstone of therapy for improving functional status.
- Percutaneous techniques or surgery are reserved for severe cases or threatened tissue.
Main Results:
- Management focuses on reducing cardiovascular events like myocardial infarction and stroke.
- Therapeutic strategies aim to enhance the daily activity level of patients.
- A conservative approach is effective for milder forms of the condition.
Conclusions:
- Comprehensive management of intermittent claudication requires addressing systemic atherosclerosis and its risk factors.
- Exercise therapy is central to improving functional outcomes.
- Interventional procedures are reserved for advanced disease stages.
Abstract:
Intermittent claudication is a symptom complex associated with atherosclerosis of the aorta and lower extremities. It is a clinical marker of systemic atherosclerosis, and therefore, management cannot be considered isolated from treatment of underlying risk factors of atherosclerosis. The focus of the management is twofold. The first is to reduce morbidity and mortality from cardiovascular events, including myocardial infarction and stroke. The second focus is to improve the functional status of patients who have impairment of daily activities secondary to symptoms of claudication through pharmacologic and rehabilitative means, that is, exercise. Exercise is the cornerstone of therapy. A conservative approach is favored in patients who have mild and moderate symptoms of claudication. Intervention with percutaneous techniques or surgery is generally reserved for patients who have severe impairment of lifestyle or threatened tissue.